These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2866553)

  • 1. The effects of putative anxiolytic compounds (PK 8165, PK 9084 and tracazolate) on the rat corticosterone response.
    File SE; Pellow S
    Physiol Behav; 1985 Oct; 35(4):583-6. PubMed ID: 2866553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of putative anxiogenic compounds (FG 7142, CGS 8216 and Ro 15-1788) on the rat corticosterone response.
    Pellow S; File SE
    Physiol Behav; 1985 Oct; 35(4):587-90. PubMed ID: 2999846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anxiolytic but not the sedative properties of tracazolate are reversed by the benzodiazepine receptor antagonist, Ro 15-1788.
    File SE; Pellow S
    Neuropsychobiology; 1985; 14(4):193-7. PubMed ID: 2872613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of acute and chronic treatment on the pro- and anti-convulsant actions of CL 218, 872, PK 8165 and PK 9084, putative ligands for the benzodiazepine receptor.
    File SE; Wilks L
    J Pharm Pharmacol; 1985 Apr; 37(4):252-6. PubMed ID: 2860223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat.
    Pellow S; File SE
    Pharmacol Biochem Behav; 1986 Mar; 24(3):525-9. PubMed ID: 2871560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of psychotomimetics and some putative anxiolytics on stress-induced hyperthermia.
    Lecci A; Borsini F; Gragnani L; Volterra G; Meli A
    J Neural Transm Gen Sect; 1991; 83(1-2):67-76. PubMed ID: 1673345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of the effects of the benzodiazepine derivative clorazepate on corticosterone secretion with its behavioural actions. Antagonism by Ro 15-1788.
    Mormede P; Dantzer R; Perio A
    Pharmacol Biochem Behav; 1984 Dec; 21(6):839-43. PubMed ID: 6151666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of benzodiazepine and GABA binding by the novel anxiolytic, tracazolate.
    Meiners BA; Salama AI
    Eur J Pharmacol; 1982 Mar; 78(3):315-22. PubMed ID: 6121710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of PK 11195, a ligand for benzodiazepine binding sites, in animal tests of anxiety and stress.
    File SE; Pellow S
    Pharmacol Biochem Behav; 1985 Nov; 23(5):737-41. PubMed ID: 3001779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anxioselective anxiolytics.
    Williams M
    J Med Chem; 1983 May; 26(5):619-28. PubMed ID: 6132997
    [No Abstract]   [Full Text] [Related]  

  • 11. Pro- and anti-convulsant drug effects in combination with the convulsant benzodiazepine Ro 5-4864.
    Pellow S; File SE
    J Pharm Pharmacol; 1985 Aug; 37(8):560-3. PubMed ID: 2864417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tracazolate reveals a novel type of allosteric interaction with recombinant gamma-aminobutyric acid(A) receptors.
    Thompson SA; Wingrove PB; Connelly L; Whiting PJ; Wafford KA
    Mol Pharmacol; 2002 Apr; 61(4):861-9. PubMed ID: 11901225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benzodiazepine-induced hyperphagia in the nondeprived rat: comparisons with CL 218,872, zopiclone, tracazolate and phenobarbital.
    Cooper SJ; Moores WR
    Pharmacol Biochem Behav; 1985 Aug; 23(2):169-72. PubMed ID: 2865747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anxiolytic-like effects of the corticotropin-releasing factor1 (CRF1) antagonist DMP904 [4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1,5-a]-pyrimidine] administered acutely or chronically at doses occupying central CRF1 receptors in rats.
    Lelas S; Wong H; Li YW; Heman KL; Ward KA; Zeller KL; Sieracki KK; Polino JL; Godonis HE; Ren SX; Yan XX; Arneric SP; Robertson DW; Hartig PR; Grossman S; Trainor GL; Taub RA; Zaczek R; Gilligan PJ; McElroy JF
    J Pharmacol Exp Ther; 2004 Apr; 309(1):293-302. PubMed ID: 14742750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The quinolines PK 8165 and PK 9084 possess benzodiazepine-like activity in vitro but not in vivo.
    Keane PE; Simiand J; Morre M
    Neurosci Lett; 1984 Mar; 45(1):89-93. PubMed ID: 6145125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology of pyrazolopyridines.
    Patel JB; Malick JB; Salama AI; Goldberg ME
    Pharmacol Biochem Behav; 1985 Oct; 23(4):675-80. PubMed ID: 2866547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of non-sedative anxiolytic drugs on responses to GABA and on diazepam-induced enhancement of these responses on mouse neurones in cell culture.
    De Deyn PP; Macdonald RL
    Br J Pharmacol; 1988 Sep; 95(1):109-20. PubMed ID: 2905900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gabamimetic properties of anxiolytic drugs.
    Goldstein JM; Knobloch LC; Malick JB
    Life Sci; 1983 Feb; 32(6):613-6. PubMed ID: 6132324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological and endocrinological characterisation of stress-induced hyperthermia in singly housed mice using classical and candidate anxiolytics (LY314582, MPEP and NKP608).
    Spooren WP; Schoeffter P; Gasparini F; Kuhn R; Gentsch C
    Eur J Pharmacol; 2002 Jan; 435(2-3):161-70. PubMed ID: 11821022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CRF(1) receptor antagonist DMP696 produces anxiolytic effects and inhibits the stress-induced hypothalamic-pituitary-adrenal axis activation without sedation or ataxia in rats.
    McElroy JF; Ward KA; Zeller KL; Jones KW; Gilligan PJ; He L; Lelas S
    Psychopharmacology (Berl); 2002 Dec; 165(1):86-92. PubMed ID: 12474122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.